NLNK - NewLink Genetics Corporation

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts6266
Avg. Estimate-0.67-0.59-2.65-2.4
Low Estimate-0.8-0.63-2.8-3.02
High Estimate-0.58-0.55-2.55-1.62
Year Ago EPS-0.46-0.72-2.94-2.65
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts6266
Avg. Estimate2.62M6.25M21.23M14.79M
Low EstimateN/A5M18.61MN/A
High Estimate5.46M7.5M24.08M30M
Year Ago Sales12.7M2.76M35.77M21.23M
Sales Growth (year/est)-79.40%126.40%-40.60%-30.30%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.62-0.82-0.73-0.74
EPS Actual-0.46-0.72-0.57-0.69
Difference0.160.10.160.05
Surprise %25.80%12.20%21.90%6.80%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.67-0.59-2.65-2.4
7 Days Ago-0.67-0.59-2.65-2.4
30 Days Ago-0.67-0.59-2.67-2.4
60 Days Ago-0.710-2.82-2.48
90 Days Ago-0.710-2.82-2.48
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/A1N/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesNLNKIndustrySectorS&P 500
Current Qtr.-45.70%N/AN/A0.22
Next Qtr.18.10%N/AN/A0.25
Current Year9.90%N/AN/A0.08
Next Year9.40%N/AN/A0.12
Next 5 Years (per annum)17.30%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A